ReviewFrontiers in immunology2021
Current Challenges for IDO2 as Target in Cancer Immunotherapy.
Giada Mondanelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this papercites it
ReviewFrontiers in immunology2021
Giada Mondanelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.